首页 | 官方网站   微博 | 高级检索  
     

中药淫羊藿主要资源种类药材质量的系统研究
引用本文:裴利宽,黄文华,何天谷,郭宝林.中药淫羊藿主要资源种类药材质量的系统研究[J].中国中药杂志,2007,32(21):2217-2222.
作者姓名:裴利宽  黄文华  何天谷  郭宝林
作者单位:1. 中国医学科学院,中国协和医科大学,药用植物研究所,北京,100094
2. 贵州省印江县杨柳乡卫生院,贵州,印江,555212
摘    要:目的:为有效实现淫羊藿药材质量控制,考察药典中规定的淫羊藿Epimedium brevicornu,箭叶淫羊藿E. sagittatum,柔毛淫羊藿E. pubescens,朝鲜淫羊藿E. koreanum和巫山淫羊藿E. wushanense等5个种,以及《贵州省中药材、民族药材标准》收载的粗毛淫羊藿E. acuminatum,天平山淫羊藿E. myrianthum,黔岭淫羊藿E. leptorrhizum 3个种,以及贵州省作为巫山淫羊藿使用的拟巫山淫羊藿E. pseudowushanuse共9个主要资源种类的药材质量情况。方法:采用HPLC,UV测定共102份不同产地的上述9种淫羊藿药材样本的淫羊藿苷、总黄酮含量,并测定了以淫羊藿苷为参照的朝藿定A,B,C和淫羊藿苷(简称淫羊藿多苷,ABCI)4种成分的总量。 结果和结论: 以药典5个品种样品计,仅约有30%的样本淫羊藿苷含量达到药典标准,本研究提出以淫羊藿多苷的总量不低于13%,总黄酮含量不低于50%作为淫羊藿药材质量控制指标,并对各品种进行了质量评价,提出这些品种作为国家标准的参考意见。

关 键 词:淫羊藿药材  淫羊藿多苷  淫羊藿苷  总黄酮  质量控制
文章编号:1001-5302(2007)21-2217-06
收稿时间:2006-12-20
修稿时间:2006年12月20

Systematic studies on quality of main species of Herba Epimedii
PEI Li-kuan; HUANG Wen-hua; HE Tian-gu; GUO Bao-lin.Systematic studies on quality of main species of Herba Epimedii[J].China Journal of Chinese Materia Medica,2007,32(21):2217-2222.
Authors:PEI Li-kuan; HUANG Wen-hua; HE Tian-gu; GUO Bao-lin
Affiliation:1. Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100094, China; 2. The Hospital of Yangliu Town, Yinjiang County, Yinjiang 555212,China
Abstract:Objective: To achieve the quality control of Herba Epimedii,and to evaluate the quality of medical materials of the 8 official species including the 5 species recorded in 'Chinese Pharmacopoeia' including Epimedium brevicornum,E.sagittatum,E.pubescens,E.koreanum and E.wushanense,and the 3 other species(E.acuminatum,E.myrianthum,E.leptorrhizum) recorded in 'Guizhou Quality Criteria for Traditional Chinese Medical Material and Nationality Medical Material',and E.pseudowushanuse(new speccies) which is used as E.wushanense for a long time.Method: The contents of icariin and total flavonoids of 102 samples of 9 officinal species of Herba Epimedii were determined by HPLC and UV,respectively.Result and Conclusion: The contents of icariin in about 30% of the samples of the 5 species recorded in 'Chinese Pharmacopoeia' were lower than 0.5%,which is acceptable quality recorded in 'Chinese Pharmacopoeia'.Refering the literatures,we suggested the total contents of epimedin A,B,C and icariin(epimedium multi-glycosides,ABCI) should be established as a new standard instead of the content of icariin.The content of total flavonoids,not less than 5.0%,and ABCI,not less than 1.3%,could be used to evaluate the quality of the above medical materials efficiently.
Keywords:HPLC  UV
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号